Safety and Efficacy of Medications COVID-19

Summary

We performed a quasi-experimental open-label pragmatic study alternating standard of care (SOC) and oral bedtime melatonin (OBM) at different high doses over 4 consecutive time periods enrolling all consecutive RT-PCR SARS-CoV-2 severe Covid-19 admissions.

Timeline

Start

2020-04-22

Primary completion

2021-05-31

Completion

2022-03-31

Drugs

Indications